Tianjin Tianyao Pharmaceuticals Co., Ltd. engages in the research and development, production, and sales of corticosteroids, amino acid active pharmaceutical ingredients (APIs), and preparations in China. Its primary products comprising corticosteroid raw materials, such as dexamethasone, prednisone, methylprednisolone, and betamethasone product series. The company provides amino acid raw materials, as well as dosage forms, including injections, ointments, creams, hard capsules, pills, freeze-dried powder injections, inhalation preparations, and tablets. It exports its products to the United States, Southeast Asia, Europe, South America, Africa, and internationally. The company was founded in 1939 and is based in Tianjin, China. Tianjin Tianyao Pharmaceuticals Co., Ltd. operates as a subsidiary of Tianjin Pharmaceutical Group Co., Ltd.
Metrics to compare | 600488 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship600488PeersSector | |
---|---|---|---|---|
P/E Ratio | 37.5x | 33.7x | −0.5x | |
PEG Ratio | 1.53 | −1.05 | 0.00 | |
Price/Book | 1.6x | 3.1x | 2.6x | |
Price / LTM Sales | 1.6x | 4.5x | 3.2x | |
Upside (Analyst Target) | - | 7.4% | 41.2% | |
Fair Value Upside | Unlock | 3.1% | 6.2% | Unlock |